Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|June 3, 2004
Antiangiogenic activity of aplidine, a new agent of marine originG Taraboletti, M Poli, R Dossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activityC Gatto, M Rieppi, P Borsotti, et al.
Oncogene|November 13, 2001
p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesisF Vikhanskaya, M R Bani, P Borsotti, et al.
Cancer Research|February 15, 1987
Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitorC Chiabrando, M Broggini, M G Castelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenograftsR Giavazzi, A Garofalo, C Ferri, et al.
International Journal of Cancer|April 10, 1995
Establishment of human acute myelogenous leukemia lines secreting interleukin-1 beta in SCID miceR Giavazzi, C Di Berardino, A Garofalo, et al.
The Journal of Clinical Investigation|November 1, 1993
A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancerN Pedersen, M Schmitt, E Rønne, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1992
Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chainE Dejana, I Martin-Padura, D Lauri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agentsM I Nicoletti, G Valoti, P Giannakakou, et al.
Leukemia|January 17, 2003
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4M Broggini, S V Marchini, E Galliera, et al.
Pageof 11